Market Cap (In KRW)
179.96 Billion
Revenue (In KRW)
9.58 Billion
Net Income (In KRW)
-9.69 Billion
Avg. Volume
133.98 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 4460.0-9300.0
- PE
- -
- EPS
- -
- Beta Value
- 0.458
- ISIN
- KR7048530000
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Seong-Jun Yoon
- Employee Count
- -
- Website
- https://www.intron.co.kr
- Ipo Date
- 2011-01-26
- Details
- iNtRON Biotechnology, Inc. develops biopharmaceuticals for the prevention and treatment of human diseases worldwide. It develops bacteriophage and endoricin drugs. The company was founded in 1999 and is headquartered in Seongnam-si, South Korea.
More Stocks
-
RBRXFRhino Biotech Limited
RBRXF
-
BASBasilix Cert
BAS
-
DXIEFDXI Capital Corp.
DXIEF
-
NFTFFNFT Technologies Inc.
NFTFF
-
241590
-
ALNXTNextedia S.A.
ALNXT
-
HEBA-BHeba Fastighets AB (publ)
HEBA-B
-
BTDR